Overview

Pilot Study to Assess Number of Patients for Main Trial

Status:
Completed
Trial end date:
2007-04-01
Target enrollment:
Participant gender:
Summary
The objective of the study was to investigate the efficacy of Bepanthen® wound healing ointment compared to placebo in a superficial abrasive wound model. The primary objective was the re-epithelization at Day 5. The secondary objectives were re-epithelization at Days 2, 3, 4, 6, 7, 8, 9, 10 and 15, assessment of cosmetic outcome/acceptance at Day 15 (investigator only) and at Day 36 (investigator and subject), and documentation and analysis of safety parameters.
Phase:
Phase 4
Details
Lead Sponsor:
Bayer
Treatments:
Pantothenic Acid